Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer's syndrome

Urology Case Reports - Tập 29 - Trang 101077 - 2020
Kevin Zarrabi1, Selma Masic2, Christopher Schaefer3, Michael J. Bartel4, Alexander Kutikov2, Matthew Zibelman1
1Department of Medical Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, United States
2Department of Urological Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, United States
3Department of Urology, Urology Care Alliance, Langhorne, PA, United States
4Department of Medicine, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, United States

Tài liệu tham khảo

MH S: Nephrogenic hepatomegaly. Gastroenterology 2961, 40:694. Blay, 1997, Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma, Int J Cancer, 72, 424, 10.1002/(SICI)1097-0215(19970729)72:3<424::AID-IJC9>3.0.CO;2-R Morla, 2006, Stauffer's syndrome variant with cholestatic jaundice: a case report, J Gen Intern Med, 21, C11, 10.1111/j.1525-1497.2006.00448.x Mejean, 2018, Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma, N Engl J Med, 379, 417, 10.1056/NEJMoa1803675 Bex, 2019, Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial, JAMA Oncol, 5, 164, 10.1001/jamaoncol.2018.5543